Federal grants to Fzata Inc
Fzata Inc in Halethorpe, Maryland received $10.4 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Allergy and Infectious Diseases Research, with $6.3 million. In fiscal 2025 more was taken back from its awards than added, a net -$249,162.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$10.4 million
- Awards5
- Awarded in FY 2025-$249,162
- Largest award$2.9 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 4 | $2.0 million |
| FY 2022 | 4 | $3.8 million |
| FY 2023 | 3 | $2.8 million |
| FY 2024 | 1 | $2.1 million |
| FY 2025 | 0 | -$249,162 |
Programs that fund Fzata Inc
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 3 | $6.3 million |
| Drug Use and Addiction Research Programs | 1 | $2.1 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $2.0 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 5 | $10.4 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| A serological assay for neutralizing antitoxin response in patients with clostridioides difficile infection (phase II) - abstract this sbir phase II project will support the development of an in vitro diagnostic blood test to determine whether a person infected with clostridioides difficile has moun | Allergy and Infectious Diseases Research | July 30, 2021 | $2.9 million |
| A yeast-based immunotherapy against clostridioides difficile infection | Allergy and Infectious Diseases Research | March 30, 2021 | $2.4 million |
| A novel oral immunotherapy for chronic visceral pain of irritable bowel syndrome - abstract: chronic visceral pain is a defining feature of irritable bowel syndrome (IBS) that is currently considered as a disorder of brain-gut interaction. Although pain is the most common driver of healthcare visits | Drug Use and Addiction Research Programs | August 29, 2024 | $2.1 million |
| Novel oral yeast immunotherapies for ulcerative colitis (fast-track) - abstract ulcerative colitis and crohn’s disease are major forms of inflammatory bowel disease (IBD), which is characterized by chronic intestinal inflammation and gut microbiota dysbiosis. Ibd has been associated with poor qualit | Diabetes, Digestive, and Kidney Diseases Extramural Research | April 27, 2021 | $2.0 million |
| A novel humanized tetra-specific antibody against clostridium difficile infection | Allergy and Infectious Diseases Research | June 16, 2021 | $963,670 |
Questions people ask
How much federal grant money does Fzata Inc get?
$10.4 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Fzata Inc the most?
The Department of Health and Human Services, with $10.4 million in 5 awards.
What is Fzata Inc's largest federal grant?
$2.9 million under Allergy and Infectious Diseases Research, with its first action in the period on July 30, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Fzata Inc?
Its largest are Allergy and Infectious Diseases Research, Drug Use and Addiction Research Programs and Diabetes, Digestive, and Kidney Diseases Extramural Research.
Other grant recipients in Halethorpe
- Astek Diagnostics Inc.
- Goodwill Industries of the Chesapeake, Inc
- RCT Systems, Inc
- Chesapeake Genomic Systems, LLC
- Vehicles for Change, Inc.
Largest federal grant recipients in Maryland · Federal grants in Maryland